|
Amborn J, Tiger V 2001. Apparatus for handling and packaging friable tablets.US Patent 6,311,462.
Alhusban FA, Elshaer AM, Jones RJ, Mohammed AR 2010. Recent patents and trends in orally disintegrating tablets. Recent Patents on Drug Delivery and Formulation. 4(3):178-197.
Biradar SS, Bhagavati ST 2006. Fast dissolving drug delivery system: a brief overview. The Internet Journal of Pharmacology. 4(2):1531-2972.
Brown D 2003. Orally disintegrating tablets: taste over speed. Drug Delivery Technology 3(6):58-61.
Bogner RH, Wilkosz M 2002. Fast-dissolving tablets: new dosage convenience for patients. US Pharmacist 27 : 34 -43.
Berry SJ, Coffey DS, Walsh PC 1984. The development of human benign prostatic hyperplasia with age. The Journal of Urology 132:474-479.
Cousin G, Bruna E, Gendrot E 1995. Rapidly disintegratable multiparticular tablet. US patent 5,464,632.
Dobetti L 2003. Fast disintegrating tablets. US Patent 6,596,311.
Dobetti L 2000. Fast-melting tablets: Developments and technologies. Pharmaceutical Technology 12(9):32-42.
European Directorate for quality of Medicines. 1998. Pharmaeuropa. 10(4):547.
Fix JA, Chu JS, Sharma K 1999. Polymer based rapidly dissolving tablets and production processes thereof. US Patent 6,465,009.
Fu Y, Yang S, Jeong SH, Kimura S 2004. Orally Fast Disintegrating Tablets: Developments, Technologies, Taste-Masking and Clinical Studies Taste-Masking and Clinical Studies. Critical Reviews™ in Therapeutic Drug Carrier Systems 21(6): 433-475.
Gregory GKE, Ho DSS 1981. Pharmaceutical dosage form package. US Patent 4,305,502.
Ghosh T, Ghosh A, Prasad D 2011. A review on new generation orodispersible tablets and its future prospective. International Journal of Pharmacy and Pharmaceuticla Sciences 3(1):0975-1491.
Goel H, Rai P, Rana V, Tiwary AK 2008. Orally Disintegrating Systems: Innovations in Formulation and Technology. Recent Patents on Drug Delivery & Formulation 2: 258-274.
Hirani JJ, Rathod DA, Vadalia KR 2009. Orally Disintegrating Tablets: A Review. Tropical Journal of Pharmaceutical Research 8(2): 161-172.
Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M 1995. New oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chemical & Pharmaceutical Bulletin 43(2):284-288.
Kakutani R, Muro H, Makino T 2010. Development of a New Disintegration Method for Orally Disintegrating Tablets. Chemical & Pharmaceutical Bulletin 58(7): 885-890.
Kim MS, Kim JS, Kang SH, Yoo YH, Lee S, Park JS, Woo JS, Hwang SJ 2007. Influence of water soluble additives and HPMCP on drug release from surelease-coated pellets containing tamsulosin hydrochloride. Archives of Pharmacal Research 30(8):1008-1013.
Kim MS, Park GD, Jun SW, Lee S, Park JS, Hwang SJ 2005. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials. Journal of Pharmacy and Pharmacology 57:1521-1528.
Kim MS, Park GD, Jun SW, Lee S, Park JS, Hwang SJ 2005. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form. Journal of Pharmacy and Pharmacology 57:735-742.
Koji M, Mitsutishi T, Toshihito S 2001. Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity. US Patent 6,316,026.
Liang AC, Chen LH 2001. Fast-dissolving intraoral drug delivery systems. Expert Opinion on Therapeutic Patents 11(6):981-986.
Lafon L 1986. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. US Patent 4,616,047.
Moore JW, Flanner HH 1996. Mathematical comparison of dissolution profiles. Pharmaceutical Technology 20(6):64-74.
Mizumoto T, Masuda Y, Kajiyama A, Yanagisawa M, Nyshadham JR 2003. Tablets quickly disintegrating in the oral cavity and process for producing the same. US Patent 6,589,554.
Morella AM, Pitman IH, Heinicke GW 2001. Taste masked liquid suspensions.US Patent 6,197,348.
Missaghi S, Young C, Fegely K 2010. Delayed release film coating application on oral solid dosage forms of proton pump inhibitors: case studies . Drug Development and Industrial Pharmacy 36(2):180-189.
Mallet L 1996. Caring for the elderly patient. Journal of American Pharmaceutical Association 36(11):628-635.
Mizumoto T, Masuda Y, Takeshi Y, Estuo Y, Katsuhide T 2005. Formulation design of a novel fast-disintegrating tablet. International Journal of Pharmaceutics 306(1-2):83-90.
Mizumoto T, Masuda Y, Fukui M. 1996. Intrabuccaly dissolving compressed moldings and production process thereof. US Patent 5,576,014.
Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T 2004. A New Method for Disintegration Studies of Rapid Disintegrating Tablet. Chemical & Pharmaceutical Bulletin 52(6): 704-707.
Nithiyananthan TS, Shankarananth V, Rajasekhar KK, Hareesh G 2009. Formulation and evaluation of tamsulosin hydrochloride as sustained release matrix tablet. International Journal of ChemTech Research 1(4) 1278-1290.
Nargund VH, Grey ADR 2008. Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses. Expert Opinion on Pharmacotherapy9(5): 813-824.
Pahwa R, Piplani M, Sharma PC, Kaushik D 2010. Orally Disintegrating Tablets-Friendly to Pediatrics and Geriatrics. Archives of Applied Science Research 2(2): 35-48.
Porter SC 2001. Novel drug delivery: Review of recent trends with oral solid dosage forms. American Pharmaceutical Review 85:28-35.
Pather SI, Khankari R, Siebert J 2005. Quick-dissolving intraoral tablets. Drug Delivery to the oral cavity: molecules to market. NY, USA:CRC Press 291-336.
Patel R, Pillay V, Choonara YE. 2007. A novel cellulose-based hydrophilic wafer matrix for rapid bioactive delivery. Journal of Bioactive and Compatible Polymers 22:119–142.
Pfister WR, Ghosh TK 2005. Orally disintegrating tablets – products, technologies, and development issues. Pharmaceutical Technology 136-150.
Reddy D, Pillay V, Choonara YE, Lisa C 2009. Rapidly disintegrating oramucosal drug delivery Technologies. Pharmaceutical Development and Technology 14(6): 588-601.
Schindler JS, Kelly JH 2002. Swallowing disorders in the elderly. Laryngoscope 112 : 589 -602.
Saigal N, Baboota S, Alka A 2008. Fast-dissolving intra-oral drug delivery systems. Expert Opinion on Therapeutic Patents 18(7): 769-781.
Sastry SV, Nyshadham JR, Fix JA 2000. Recent technological advances in oral drug delivery-a review. Pharmaceutical science technology today 3(4): 138-145.
Seager H 1998. Drug-delivery Products and the Zydis Fast-dissolving Dosage Form. Journal of pharmacy and Pharmacology 50: 375-382.
Shukla D, Chakraborty S, Singh S, Mishra B 2009. Mouth Dissolving Tablets II: An Overview of Evaluation Techniques. Scientific Pharmaceuticals 77: 327–341.
Sastry SV, Nyshadham JR, Fix JA 2000. Recent technological advances in oral drug delivery. A review. Pharmaceutical Science & Technology Today 3(4):138-145.
Seager H 1998. Drug-delivery products and the Zydis fast-dissolving dosage form. Journal of Pharmacy and Pharmacology 50(4):375-382.
Shukla D, Chakraborty S, Singh S, Mishra B 2009. Mouth dissolving tablets I: An overview of formulation technology. Scientific Pharmaceuticals 77:309-326.
Sreenivas SA 2005. Orodispersible tablet: new- fangled drug delivery system- a review. Indian Journal of Pharmaceutical Education & Research 39(4):177-81.
Shyamala B, Narmada GY 2002. Rapid dissolving tablets: A novel dosage form. The Indian Pharmacist 13(8):09-12.
Stoner E 1992. The Finasteride Study Group. The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Journal of Urology 147:1298-1302.
Terebesi I, Bodmeier R 2010. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets. European Journal of pharmaceutics and biopharmaceutics 75:63-70.
Takao M, Janaki RN, Yoshinori M, Masahiro Y, Atsushi K 2003. Tablets quickly disintegrating in the oral cavity and process for producing the same. US Patent 6,589,554.
Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R 2004. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Development and Industrial Pharmacy 30(5):525-34.
Verma RK, Garg S 2001. Current status of drug delivery technology and future directions. Pharmaceutical Technology 25 : 1 -14.
Wehling F, Schuehle S 1996. Base coated acid particles and effervescent formulation incorporating same. US Patent 5,503,846.
Wehling F, Schuehle S, Madamala N 1993. Effervescent dosage form with microparticles. US Patent 5,178,878.
Wilson CG, Washington N, Peach J, Murray GR, Kennerley J 1987. The behavior of a fast dissolving dosage form (Expidet) followed by -scintigraphy. International Journal of Pharmaceutics 40:119–123.
Yarwood R, Kearnery P, Thompson A 1995. Process for preparing solid pharmaceutical dosage form. US Patent 5,738,875.
Zhang X, Tang X, Yang R 2009. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Development and Industrial Pharmacy 35:26-33.
|